Spravato (Esketamine) Reimbursement Guide – Missouri

Prepared for ROI Logistics / Go AI Labs / Sinapsis Psychiatry Review
Date: July 22, 2026
Focus: Missouri Medicaid (MO HealthNet), Missouri Medicare (Part B), and General Commercial Carriers

Executive Summary

Spravato (esketamine nasal spray) is covered under the medical benefit in REMS-certified healthcare settings for Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD) with acute suicidal ideation/behavior (in conjunction with an oral antidepressant).

Key Requirements Across All Payers: - REMS-certified treatment center (free certification via spravatorems.com). - 2-hour post-administration monitoring. - Prior Authorization (PA) almost always required. - Diagnosis documentation (DSM-5, validated depression scales like MADRS, PHQ-9). - Buy-and-bill model for most settings (purchase from authorized distributors such as Henry Schein).

1. Missouri Medicaid (MO HealthNet)

Coverage & Clinical Criteria

• Indications: TRD in adults + MDD with acute suicidal ideation/behavior.
• Age: 18+.
• Prescriber: Psychiatrist or in consultation with one (or PMHNP/PA specialist).
• Requirements:
• Failure of ≥2 antidepressants from different classes (≥6 weeks each at adequate doses) in current episode.
• Augmentation trial (antipsychotic, lithium, etc.) or ECT/TMS.
• Concurrent oral antidepressant.
• REMS-certified setting + 2-hour monitoring.
• Baseline and follow-up depression rating scale scores.

Renewal: Initial PA 4 weeks; renewals up to 6–12 months with documented improvement and compliance.

Source: MO HealthNet Drug PA criteria (March 2022 and updates).

Prior Authorization

• Submit via MO HealthNet Drug PA form (mydss.mo.gov).
• Required for all requests.
• Exception code for denial if criteria not met.

Billing Codes

• Drug: HCPCS J0013 – Esketamine, nasal spray, 1 mg
  Units = milligrams administered (56 units for 56 mg dose; 84 units for 84 mg dose).
• NDC: Use exact 11-digit NDC from the kit administered (e.g., 50458-028-02 for 56 mg kit).
• Administration/Monitoring: Appropriate E/M code + prolonged service or observation codes for the 2-hour supervised session.
• Place of Service: REMS-certified outpatient clinic.

Reimbursement Methodology

• Drug Payment: Actual Acquisition Cost (AAC) from invoice (Henry Schein or authorized distributor) + professional dispensing fee.
• Professional Dispensing Fee: Approximately $8.85 – $12.22 (in-state providers; confirm current fee schedule on mydss.mo.gov).
• Example at $149 AAC (your quoted volume price):
• Drug line: $149
• Dispensing fee: ~$10–$12
• Total estimated reimbursement per dose: $159 – $161
• Higher AAC ($700–$900/kit) yields proportionally higher reimbursement but requires more upfront capital.
• No percentage markup — strictly AAC + flat fee.
• Attach invoice for AAC validation on claims.

REMS & Operational Requirements

• Clinic must be REMS-certified.
• No direct dispensing to patients.
• Maintain lot traceability.
• 2-hour monitoring mandatory.

Key References

• MO HealthNet Spravato PA criteria PDF
• Outpatient Billing for Spravato guidance (mydss.mo.gov)
• Behavioral Health Services Provider Manual

Cash Flow Note: Lower AAC dramatically improves margins and reduces working capital needs.

2. Missouri Medicare (Part B)

Coverage

• Covered under Part B (medical benefit) when administered in REMS-certified settings.
• Dual eligibles: Medicaid as secondary payer.

Billing Codes (2026)

• Primary Codes:
• G2082: Office/outpatient visit + up to 56 mg esketamine + 2-hour post-administration observation (bundled).
• G2083: Same but for >56 mg (typically 84 mg).
• J0013 is Medicare non-payable — do not use for Medicare claims.
• Some transitional use of J3490 (unclassified) possible but G-codes preferred.

Reimbursement Rates (National Averages – 2026)

• G2082 (56 mg bundle): ~$952 – $957
• G2083 (84 mg bundle): ~$1,356
• Rates vary by Medicare Administrative Contractor (MAC) locality and facility vs. non-facility status.
• Includes drug cost + physician supervision + mandatory 2-hour observation.

REMS Requirements

• Same as Medicaid: Certified setting, 2-hour monitoring, patient enrollment in REMS.

Key Notes for Missouri

• Confirm with your MAC (e.g., WPS or Noridian for Missouri region) for exact locality-adjusted rates.
• Buy-and-bill model standard.

3. Commercial Insurance Carriers (General / Missouri)

Overview

Commercial reimbursement is highly contract-dependent and does not follow strict AAC methodology. Payment is based on negotiated allowed amounts, fee schedules, or percentage of billed charges.

Typical Billing Approaches

• Drug: J0013 (most common post-2026) or S0013 (transitional in some plans). Bill units = mg administered.
• Bundled: Many payers accept or prefer G2082 / G2083 structure.
• Unbundled: Drug (J0013) + E/M code + prolonged service codes (e.g., 99417) for monitoring.
• NDC Requirement: Almost always required on drug line.

Reimbursement Ranges (2026 Benchmarks)

• National Median (J0013): ~$14.75 per mg unit (as of early 2026).
• Major payers (BCBS/Anthem, UnitedHealthcare, Aetna, Cigna) in Missouri generally follow Medicare G-code structure or J0013 with negotiated rates 90–130% of Medicare.
• Some plans reimburse drug at lower % of billed while paying well for the professional services component.

Prior Authorization & REMS

• Nearly universal PA requirement with TRD documentation.
• REMS certification mandatory for in-network payment.
• Some payers cover under medical benefit only; others allow pharmacy benefit in limited cases.

Missouri-Specific Considerations

• Largest carriers: Anthem Blue Cross Blue Shield of Missouri, UnitedHealthcare Community Plan (sometimes overlaps with Medicaid), Cigna, Aetna.
• Negotiated rates vary significantly by practice size, volume, and existing contracts.
• Recommendation: Pull fee schedules from your top 3–5 commercial contracts and compare allowed amounts for G2082/G2083 or J0013.

Cash Flow & Contracting Tips

• Commercial often pays faster than government payers once contracted.
• Volume commitments or "key account" pricing (as you have with Henry Schein) can improve both acquisition cost and reimbursement.
• Consider separate professional fee schedules for monitoring time.

Summary Comparison Table

Recommendations & Next Steps

1. Confirm Henry Schein Pricing: Get written confirmation of your $149/dose rate and volume terms in writing for AAC documentation.
2. REMS Certification: Ensure clinic is fully certified before first claim.
3. Pull Contracts: Review fee schedules for top commercial payers.
4. Sample Claims: Test with small volume once PA approved.
5. Cash Flow Modeling: At $149 AAC, Medicaid margins are strong; commercial offers higher upside but more variability.
6. Contact Points: - MO HealthNet Pharmacy Help Desk: (573) 751-6963 - Spravato REMS: 1-855-382-6022 - Henry Schein Spravato team: 888-229-3270

Document prepared for agent review. All rates are 2026 benchmarks and subject to change — always verify with current fee schedules and payer contracts.

Sources: MO HealthNet official criteria, CMS 2026 PFS, Spravato HCP resources, billing industry benchmarks (Neolytix, Osmind, etc.). Verify locally before implementation.